“XP-23829, a Novel Fumaric Acid Ester, Is Efficacious in Reducing Psoriatic Lesions: Results from a Phase 2 Randomized Controlled Study”. 2017. SKIN The Journal of Cutaneous Medicine 1 (3.1): s33. https://doi.org/10.25251/skin.1.supp.32.